Morgan Stanley »

Neurogene shares owned by Morgan Stanley

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $26M 517k 50.90

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Neurogene

EcoR1 Capital
Samsara BioCapital
Dr. Jeffrey R. Jay, M.D.
Redmile Group
BlackRock
Henderson Group
Cormorant Asset Management
Casdin Capital
Morgan Stanley
Vanguard Group
Avidity Partners Management
Baker Bros. Advisors
Arrowpoint Asset Management
Commodore Capital
Adage Capital Partners GP

View all funds holding Neurogene